Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation
- PMID: 365218
- DOI: 10.1111/j.1365-2141.1978.tb05837.x
Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation
Abstract
The fibrinogen and fibrin degradation products (FDP) in serum samples taken from nine patients with suspected disseminated intravascular coagulation have been characterized using a method of immunoprecipitation followed by sodium dodecyl sulphate polyacrylamide gel electrophoresis. Aall of the serum samples contained a fragment with the same electrophoretic mobility as fibrinogen fragment X, while the majority also had evidence of fragments with similar mobility to fibrinogen fragments Y and D. In eight of the nine serum samples there was strong evidence of the D-dimer fragment that is released by plasmin lysis of crosslinked fibrin. Also present in all but one of the samples were fragments of higher molecular weight than fibrinogen which were probably soluble, non-clottable, factor XIIIa induced crosslinked derivatives of fibrinogen. These results suggest that during disseminated intravascular coagulation thrombin and activated factor XIII act upon fibrin(ogen) to form complexes that are subsequently lysed by plasmin to produce soluble crosslinked derivatives of fibrin.
Similar articles
-
Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.Thromb Haemost. 1997 Sep;78(3):1069-78. Thromb Haemost. 1997. PMID: 9308756
-
Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.Am J Clin Pathol. 1987 Jan;87(1):94-100. doi: 10.1093/ajcp/87.1.94. Am J Clin Pathol. 1987. PMID: 3541576
-
[Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].Rinsho Byori. 1990 Feb;38(2):201-7. Rinsho Byori. 1990. PMID: 2329722 Japanese.
-
Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.Semin Thromb Hemost. 2001 Dec;27(6):657-66. doi: 10.1055/s-2001-18870. Semin Thromb Hemost. 2001. PMID: 11740689 Review.
-
Assessment of hypercoagulable states by measurement of activation fragments and peptides.Blood Rev. 1990 Mar;4(1):25-40. doi: 10.1016/0268-960x(90)90014-j. Blood Rev. 1990. PMID: 2182146 Review.
Cited by
-
Increased concentrations of D-dimers in newborn infants.Arch Dis Child. 1990 Apr;65(4 Spec No):383-4. doi: 10.1136/adc.65.4_spec_no.383. Arch Dis Child. 1990. PMID: 2337364 Free PMC article.
-
Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women.Br J Cancer. 1992 Oct;66(4):744-7. doi: 10.1038/bjc.1992.350. Br J Cancer. 1992. PMID: 1419616 Free PMC article. Clinical Trial.
-
Role of fibrin D-dimer testing in emergency medicine.Emerg Med J. 2003 Jul;20(4):319-25. doi: 10.1136/emj.20.4.319. Emerg Med J. 2003. PMID: 12835339 Free PMC article. Review.
-
Distinction between fibrinogen and fibrin degradation products produced during disseminated intravascular coagulation in childhood.Eur J Pediatr. 1982 Feb;138(1):46-8. doi: 10.1007/BF00442327. Eur J Pediatr. 1982. PMID: 7075627 No abstract available.
-
Quantitative estimation of Serum Fibrinogen Degradation Product levels in Oral Premalignant and Malignant lesions.J Int Oral Health. 2013 Oct;5(5):65-72. Epub 2013 Oct 26. J Int Oral Health. 2013. PMID: 24324307 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources